lung cancer | PharmaTimes

Lab-grown lung cancer cells show potential to revolutionise treatment

Ella Day — Thu, 10 Apr 2025 11:21:07 +0000

The model could lead to more targeted treatments for the disease

Jen Brogan — Thu, 08 Aug 2024 09:59:00 +0000

Lung cancer accounts for an estimated two million global diagnoses and 1.8 million deaths

Jen Brogan — Tue, 11 Jun 2024 10:15:11 +0000

The leading cause of cancer globally accounts for an estimated 1.8 million deaths annually

Jen Brogan — Mon, 03 Jun 2024 10:29:00 +0000

The platform will be used to diagnose and treat cancers, including lung and brain tumours

Jen Brogan — Wed, 22 May 2024 10:54:55 +0000

Currently the third most common cancer in the UK, lung cancer affects 40,000 people annually

Jen Brogan — Fri, 12 Apr 2024 09:50:18 +0000

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases

Jen Brogan — Wed, 03 Apr 2024 10:27:26 +0000

The third most common and serious form of cancer affects over 43,000 people every year in the UK

Jen Brogan — Fri, 01 Mar 2024 11:36:13 +0000

TMR-CT will help doctors select treatment and predict the spread of lung cancer in patients

Jen Brogan — Tue, 13 Feb 2024 07:39:45 +0000

The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359

Jen Brogan — Thu, 11 Jan 2024 11:08:11 +0000

The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser